Cargando…
Predicting clinical outcomes in neuroblastoma with genomic data integration
BACKGROUND: Neuroblastoma is a heterogeneous disease with diverse clinical outcomes. Current risk group models require improvement as patients within the same risk group can still show variable prognosis. Recently collected genome-wide datasets provide opportunities to infer neuroblastoma subtypes i...
Autores principales: | Baali, Ilyes, Acar, D Alp Emre, Aderinwale, Tunde W., HafezQorani, Saber, Kazan, Hilal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889397/ https://www.ncbi.nlm.nih.gov/pubmed/30621745 http://dx.doi.org/10.1186/s13062-018-0223-8 |
Ejemplares similares
-
Modeling the combined effect of RNA-binding proteins and microRNAs in post-transcriptional regulation
por: HafezQorani, Saber, et al.
Publicado: (2016) -
DriveWays: a method for identifying possibly overlapping driver pathways in cancer
por: Baali, Ilyes, et al.
Publicado: (2020) -
RNA-Scoop: interactive visualization of transcripts in single-cell transcriptomes
por: Stephenson, Maria, et al.
Publicado: (2021) -
Integrative analysis of neuroblastoma and pheochromocytoma genomics data
por: Szabó, Peter M, et al.
Publicado: (2012) -
RL-MLZerD: Multimeric protein docking using reinforcement learning
por: Aderinwale, Tunde, et al.
Publicado: (2022)